The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2024 | Insights into the importance of a multidisciplinary approach when treating amyloidosis
Saurabh Zanwar, MD, Mayo Clinic, Rochester, MN, highlights the importance of adopting a multidisciplinary approach when treating patients with amyloidosis, emphasizing the importance of close collaboration between cardiologists, neurologists, and nephrologists. Patients with light chain (AL) amyloidosis are very susceptible to fluid changes and need to be monitored for heart failure as well as neuropathy. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
